Emerging Trends in Excipients: Fostering Sustainability, Encouraging Innovation, and Enhancing Personalization

Sustainable and green excipients gain strong demand. Starch-based and cellulose-derived materials offer biodegradable alternatives to synthetic polymers.

Sustainable and Green Excipients. With environmental sustainability becoming a priority, there is an increasing demand for "green" excipients derived from natural, renewable sources. For example, starch-based excipients like maize or tapioca starch are being used as binders and fillers, providing a biodegradable alternative to synthetic compounds such as polyvinylpyrrolidone (PVP). Another example is cellulose, derived from plant materials, which is used in extended-release tablets for its biodegradability and minimal environmental impact. Companies like Roquette and DuPont are actively developing sustainable excipients that comply with green chemistry principles.

As regulatory pressures around environmental sustainability grow, using such eco-friendly excipients is expected to expand significantly, creating commercial opportunities.

Additionally, lipids and polymers like polyethylene glycol (PEG) are employed in nanoparticle formulations for targeted drug delivery, particularly in cancer treatments [5].

Excipients are also critical in 3D-printed pharmaceuticals, where they enable precision drug targeting and controlled-release formulations. A notable example is FabRx’s Printlets, which use excipients to produce 3D-printed tablets with customisable release profiles for personalised medicine [6]. Such innovations in excipients are expected to drive future growth in the drug delivery market.

Excipients for Personalised Medicine Personalised medicine is transforming pharmaceutical development and excipients are pivotal in creating customised drug formulations. Excipients like mannitol and hydroxypropyl methylcellulose (HPMC) are commonly used in orodispersible films and tablets, which can be tailored to meet individual patient needs based on dosage and condition [7]. Furthermore, AI and digital health technologies facilitate the development of excipient-based formulations for personalised treatment, allowing for patient-specific drug releases [8]. This is particularly beneficial in treating chronic diseases, where individual variability in treatment response requires customisation of both the drug and the excipients involved in its delivery.

Conclusion: Sustainability, advanced functionality and personalisation are reshaping the excipient landscape. Green excipients align with the pharmaceutical industry's environmental goals, while functional excipients improve drug delivery and personalised formulations are pushing the boundaries of patient care. These trends highlight the critical role excipients will play in the future of pharmaceuticals, offering both commercial opportunities and innovative solutions.